Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma.

Suppression of p21 has been implicated in the genesis and progression of many human malignancies. DNA methylation is an important mechanism of gene silencing in human malignancies. In this study, we examined the expression status and aberrant methylaion of p21 in lung cancers and malignant pleural mesotheliomas (MPM). We used 12 small cell lung cancer (SCLC) cell lines, 13 non-small cell lung cancer (NSCLC) cell lines, 50 primary NSCLCs, 6 MPM cell lines and 10 primary MPMs. The expression and methylation of p21 was examined by reverse transcription-PCR (RT-PCR), Western blotting and methylation-specific PCR (MSP) assay. Loss of p21 protein expression was observed in 7 SCLC cell lines (58.3%), 5 NSCLC cell lines (38.5%) and 3 MPM cell lines (50%) while mRNA expression was lost in 2 SCLC cell lines (16.7%), 2 NSCLC cell lines (15.4%) and none of the MPM cell lines. Aberrant methylation of p21 was found in 8.3% of SCLC cell lines, 30.2% of NSCLCs and 6.3% of MPMs. Among primary NSCLCs, methylation in adenocarcinomas was significantly more frequent than in squamous cell carcinomas. Loss of p21 expression was frequently observed in lung cancers and MPMs and aberrant methylation was one of the mechanisms of suppression of p21, especially in NSCLCs.

[1]  J. Minna,et al.  DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.

[2]  A. Gartel,et al.  p21—Negative Regulator of the Cell Cycle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  U. Lehmann,et al.  Absence of p21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AML , 2005 .

[4]  J. Minna,et al.  Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. , 2001, Cancer research.

[5]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[6]  You-yong Lu,et al.  Effects of histone acetylation and DNA methylation on p21( WAF1) regulation. , 2002, World journal of gastroenterology.

[7]  M. Kwon,et al.  p21 as a prognostic factor in non-small cell lung carcinomas. , 2006, Pathology, research and practice.

[8]  M. Loda,et al.  Down‐regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer , 2006, The Journal of pathology.

[9]  C. Plass,et al.  Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter , 2003, Molecular and Cellular Biology.

[10]  S. Kaul,et al.  CARF: An emerging regulator of p53 tumor suppressor and senescence pathway , 2009, Mechanisms of Ageing and Development.

[11]  J. Jassem,et al.  Absence of prognostic significance of p21WAF1/CIP1 protein expression in non-small cell lung cancer , 2005, Acta oncologica.

[12]  Q. Tao,et al.  Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas. , 2004, Blood.

[13]  M. Santini,et al.  Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival , 2002, Thorax.

[14]  J. A. Castillejo,et al.  5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. , 2002, Blood.